Quantbot Technologies
HARP

Quantbot Technologies’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Quantbot Technologies’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-160
Closed -$1K – 2230
2022
Q3 		$1K Sell
160
-200
-56% -$3.73K ﹤0.01% 1533
2022
Q2 		$6K Hold
360
– – ﹤0.01% 1578
2022
Q1 		$17K Sell
360
-130
-27% -$6.74K ﹤0.01% 1399
2021
Q4 		$36K Buy
490
+190
+63% +$13K ﹤0.01% 1110
2021
Q3 		$23K Buy
+300
New +$30.2K ﹤0.01% 1244

Other funds holding HARP

MPM BioImpact
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
New Leaf Venture Partners
New Leaf Venture Partners New York $43M AUM 33.95% 1-Year Est. Return
MPM Asset Management
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Quantbot Technologies's HARP Position: Q4 2022 in Review

Quantbot Technologies sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2022, closing a stake of 160 shares — an estimated $1K sold.

Quantbot Technologies first reported a position in HARP in Q3 2021 and held it in 5 quarters. The position peaked at $36K in Q4 2021. 49 funds tracked by Wall St. Rank hold HARP as of Q4 2022.

  • Quantbot Technologies reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Quantbot Technologies sold 160 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1K.
  • Quantbot Technologies first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Quantbot Technologies's Harpoon Therapeutics, Inc. Common Stock position peaked at $36K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Quantbot Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.